Risk Factors Associated with Antibiotic Exposure Variability in Critically Ill Patients: A Systematic Review

被引:0
作者
Gras-Martin, Laura [1 ,2 ,3 ]
Plaza-Diaz, Adrian [1 ,2 ]
Zarate-Tamames, Borja [1 ,2 ]
Vera-Artazcoz, Paula [2 ,3 ,4 ]
Torres, Olga H. [2 ,3 ,5 ]
Bastida, Carla [6 ,7 ]
Soy, Dolors [6 ,7 ]
Ruiz-Ramos, Jesus [1 ,2 ,3 ]
机构
[1] Hosp Santa Creu i St Pau, Pharm Dept, St Antoni Maria Claret 167, Barcelona 08025, Spain
[2] Inst Recerca St Pau IR St PAU, Sat Quinti 77-79, Barcelona 08041, Spain
[3] Univ Autonoma Barcelona, Dept Med, Bellaterra 08193, Spain
[4] Hosp Santa Creu i St Pau, Intens Care Dept, St Antoni Maria Claret 167, Barcelona 08025, Spain
[5] Hosp Samta Creu i St Pau, Internal Med Dept, Geriatr Unit, St Antoni Maria Claret 167, Barcelona 08025, Spain
[6] Hosp Clin Barcelona, Pharm Dept, Div Med, Villarroel 170, Barcelona 08036, Spain
[7] Univ Barcelona, Fac Pharm, Dept Pharmacol, Toxicol & Therapeut Chem, Ave de Joan XXIII 27-31, Barcelona 08028, Spain
来源
ANTIBIOTICS-BASEL | 2024年 / 13卷 / 09期
关键词
pharmacokinetics; pharmacodynamics; critically ill patients; antibiotic; exposure; target attainment; risk factors; RENAL REPLACEMENT THERAPY; CONTINUOUS VENOVENOUS HEMOFILTRATION; INTENSIVE-CARE-UNIT; LOW-EFFICIENCY DIALYSIS; PIPERACILLIN POPULATION PHARMACOKINETICS; VENTILATOR-ASSOCIATED PNEUMONIA; NEGATIVE BACTERIAL-INFECTIONS; ACUTE KIDNEY INJURY; CONTINUOUS-INFUSION; SEPTIC PATIENTS;
D O I
10.3390/antibiotics13090801
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
(1) Background: Knowledge about the behavior of antibiotics in critically ill patients has been increasing in recent years. Some studies have concluded that a high percentage may be outside the therapeutic range. The most likely cause of this is the pharmacokinetic variability of critically ill patients, but it is not clear which factors have the greatest impact. The aim of this systematic review is to identify risk factors among critically ill patients that may exhibit significant pharmacokinetic alterations, compromising treatment efficacy and safety. (2) Methods: The search included the PubMed, Web of Science, and Embase databases. (3) Results: We identified 246 observational studies and ten clinical trials. The most studied risk factors in the literature were renal function, weight, age, sex, and renal replacement therapy. Risk factors with the greatest impact included renal function, weight, renal replacement therapy, age, protein or albumin levels, and APACHE or SAPS scores. (4) Conclusions: The review allows us to identify which critically ill patients are at a higher risk of not reaching therapeutic targets and helps us to recognize the extensive number of risk factors that have been studied, guiding their inclusion in future studies. It is essential to continue researching, especially in real clinical practice and with clinical outcomes.
引用
收藏
页数:27
相关论文
共 309 条
[1]   Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# [J].
Abdul-Aziz, Mohd H. ;
Alffenaar, Jan-Willem C. ;
Bassetti, Matteo ;
Bracht, Hendrik ;
Dimopoulos, George ;
Marriott, Deborah ;
Neely, Michael N. ;
Paiva, Jose-Artur ;
Pea, Federico ;
Sjovall, Fredrik ;
Timsit, Jean F. ;
Udy, Andrew A. ;
Wicha, Sebastian G. ;
Zeitlinger, Markus ;
De Waele, Jan J. ;
Roberts, Jason A. .
INTENSIVE CARE MEDICINE, 2020, 46 (06) :1127-1153
[2]   Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit [J].
Abdul-Aziz, Mohd H. ;
Abd Rahman, Azrin N. ;
Mat-Nor, Mohd-Basri ;
Sulaiman, Helmi ;
Wallis, Steven C. ;
Lipman, Jeffrey ;
Roberts, Jason A. ;
Staatz, Christine E. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) :206-214
[3]   Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort [J].
Abdul-Aziz, Mohd H. ;
Lipman, Jeffrey ;
Akova, Murat ;
Bassetti, Matteo ;
De Waele, Jan J. ;
Dimopoulos, George ;
Dulhunty, Joel ;
Kaukonen, Kirsi-Maija ;
Koulenti, Despoina ;
Martin, Claude ;
Montravers, Philippe ;
Rello, Jordi ;
Rhodes, Andrew ;
Starr, Therese ;
Wallis, Steven C. ;
Roberts, Jason A. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (01) :196-207
[4]   Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development [J].
Abdul-Aziz, Mohd H. ;
Lipman, Jeffrey ;
Mouton, Johan W. ;
Hope, William W. ;
Roberts, Jason A. .
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (01) :136-153
[5]   Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT) [J].
Abdulla, Alan ;
Dijkstra, Annemieke ;
Hunfeld, Nicole G. M. ;
Endeman, Henrik ;
Bahmany, Soma ;
Ewoldt, Tim M. J. ;
Muller, Anouk E. ;
van Gelder, Teun ;
Gommers, Diederik ;
Koch, Birgit C. P. .
CRITICAL CARE, 2020, 24 (01)
[6]   Population pharmacokinetics and target attainment of ciprofloxacin in critically ill patients [J].
Abdulla, Alan ;
Rogouti, Omar ;
Hunfeld, Nicole G. M. ;
Endeman, Henrik ;
Dijkstra, Annemieke ;
van Gelder, Teun ;
Muller, Anouk E. ;
de Winter, Brenda C. M. ;
Koch, Birgit C. P. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (07) :957-967
[7]   Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains [J].
Adnan, Syamhanin ;
Li, Janice Xuanhui ;
Wallis, Steven C. ;
Rudd, Michael ;
Jarrett, Paul ;
Paterson, David L. ;
Lipman, Jeffrey ;
Udy, Andrew A. ;
Roberts, Jason A. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (01) :90-93
[8]   Modified Augmented Renal Clearance score predicts rapid piperacillin and tazobactam clearance in critically ill surgery and trauma patients [J].
Akers, Kevin S. ;
Niece, Krista L. ;
Chung, Kevin K. ;
Cannon, Jeremy W. ;
Cota, Jason M. ;
Murray, Clinton K. .
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 77 :S163-S170
[9]   Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients [J].
Al-Shaer, Mohammad H. ;
Rubido, Eric ;
Cherabuddi, Kartikeya ;
Venugopalan, Veena ;
Klinker, Kenneth ;
Peloquin, Charles .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (12) :3644-3651
[10]   Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study [J].
Alihodzic, Dzenefa ;
Wicha, Sebastian G. ;
Frey, Otto R. ;
Koenig, Christina ;
Baehr, Michael ;
Jarczak, Dominik ;
Kluge, Stefan ;
Langebrake, Claudia .
PHARMACEUTICS, 2022, 14 (05)